FLT3-ITD results in the constitutive activation of the downstream MEK/ERK, PI3K/AKT, and JAK2/STAT5 pathways, which promote the survival and proliferation of AML cells [7]. This evidence concerns the gene MAP2K7 and acute myeloid leukemia.